• Other
  • Exited

Valeritas, Inc. is committed to developing and commercializing innovative treatment solutions that contribute to clinical and humanistic outcomes for patients, with an initial focus on the treatment of Type II diabetes. Valeritas’ portfolio is headlined by the V-Go®, a disposable insulin delivery device that delivers insulin at a continuous preset basal rate and on-demand bolus dosing. V-Go® was launched in the US in 2013.

valeritas.com